LONDON: A Canadian proven nasal spray is being tested to prevent COVID-19 infections in Britain.
The nitric oxide sprayer, developed by Vancouver-based SaNOtize, is designed to prevent the spread of the virus from the nose to the respiratory system.
Physicians are being tested at Ashford and St Peter’s Hospitals NHS Foundation Trust (National Health Service) in Surrey with pupils from Royal Holloway, University of London.
Studies have found that nitric oxide, the main component of the sprayer, is effective in stopping the spread of viral infection.
“The treatment of SaNOtize should be seen as an effective treatment for the upper airways, similar to when people use hand sanitizers to clean their hands,” said Rob Wilson, former Conservative MP. route in Surrey.
“This simple treatment will help us to restart something that comes close to normal social life … Even if we introduce the virus, we can both protect against it and protect it. destroy by using the solution regularly. ”
In Canada, the SaNOtize sprayer is undergoing a second phase of testing after the first round was found to have 100 percent efficacy in preventing COVID-19 from entering into the respiratory system.
The main infectious route of the nasal virus is through aerosol droplets, leading to multiple attempts to produce an effective antiviral nasal spray.
Some sparks may be effective in reducing transmission, but they have all relied on regular use and did not provide permanent protection.
SaNOtize hopes to block the transmission, saying that the unparalleled result is in blocking the process by which the virus attaches itself to receptors in the nasal passage.
The sprayer “provides a barrier,” said Chris Miller, the company’s chief science officer, who says it “prevents and treats early infections by destroying the virus and inhibit viral reproduction within the cells in the nose. ”